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origin. However, ERIC-PCR only dif6eremiated five genotypes 
(5/7). Amplification profiles obtained with primer AF'3 showed 911 1 
bands ranging from 275 to 2474 bp,. whereas with primer ERIC2 
were 10/11 hgments h m  296 to 2585 bp. 
Conclusions: Our results showed that AP-PCR had a higher 
discriminatory power than ERIC-PCR for the genetic typing of the 
C. albicans strains studted. On the other hand, we conclude that, in 
our study, endogenous strains are the origin of C. albicans nosocomial 
mfections, as also described by other authors. 
P355 I Microbiological Variants of Vaginal 
Candida-Infection 
AS.  Anlurshya, VV Muraviova. Research Centre o f O b / G y n  €+ 
Perinatology, Moscow, Russia 
Vaginal ecology was evaluated in 103 women having Candida spp. 
positive in vaginal cultures. The following signs were registered 
quantum of the associants in microcenosis; microscopy of the vagi- 
nal gram-smears; S/L-index. Three variants of Candtda-infection 
were determined. I. Vaginal yensfs carriage: Low titer of the yeasts 
(<lo3 CFU/ml) in combination with high titer of Lactobacillus 
(>lo6 CFU/ml), S/L-index <0.4, gram-stain did not reveal yeasts, 
none of leucocytes. Treatment was not required. 11. Wginal candido- 
six: High titer of Candida (>lo4 CFU/ml) was combined with high 
titer of Lactobacillus (?lo6 CFU/ml), S/L-index <0.4, gram-stain 
revealed yeast cells and often pseudohyphae, the leucocytic reaction 
was marked. Antimycotices were effective. 111. Variant ofbaterial uagi- 
nosir: High titer of Candida coexisted with high titer of obligatory 
anaerobes and G. uaginalis (>lo9 CFU/ml), Lclctobacillus was absent, 
S/L-index >0.4, gram-stain revealed "clue" cells, leucocytes, yeast 
cells and pseudohyphae. Treatment was successful only in combina- 
tion of antimycotic and antianaerobic antibiotics. 
I P356 I Detection of Circulating Galactornannan of 
Aspergillus in Patients with Hematological 
Malignancies 
S. Tsoulfa, A. Kontodimou, E. Tsorlini, A. Fassas, G. Tsoulfas. 
Department of Clinical Microbiology, "G. Paponikolaou" General 
Hospital, Thessaloniki, Greece 
Invasive aspergillosis is a severe apportunistic mfection, occurring 
with increasing fkquency in patients with hematologcal malignan- 
cies. Since clinical diagnosis, isolation of Aspergillus and detection 
of antibodies in immunocompromised patients are often a c u l t ,  
circulating antigen detection tests have been applied. 
In our study we detected Galactomannan antigen of Aspergillus 
using a simple latex agglutination test (pastorex Asperflus) in 197 
serum samples &om 58 patients of the Hematological Department, 
suffering from leukemia, H o w  and non Hod* lymphoma. 
Our patients were neutropenic and were treated with corticosteroids 
and cytotoxic regimens. 49 of them underwent bone marrow trans- 
plantation. 23 had clinically proven or suspected aspergillosis. Pa- 
storex became positive in 63 serum specimens, collected &om 32 
patients, whereas Aspergillus was isolated by sputum culture of only 
one patient. The sensitivity correspondmg to the clmical and radio- 
logical findings w a s  91.3%. 
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I P357 1 Evaluation of the E-Test for Antifungal 
Sensitivity Testing 
I.M. Gould, K. Milne. Dept. ofkficrobiology, Royal Injrmary, 
Aberdeen, Scotland 
The susceptibility of 4 Candida albicans, 5 C. inconspicua, 1 C. guiller- 
mondii, 2 C. lusitaniae, 2 C. parapsilosis, 1 C. tropicalis, 8 Torulopsis 
glabrata and 3 Sactharomyces cereuisiae to the antifungal agents Am- 
photericin B (AMP), 5 Flumcytosine (5FC), Fluconazole (FLU) and 
Itraconazole (ITR) were determined by a broth microdilution (BM) 
method and by E-test. RPMI1640 medium with 0.165M MOPS 
at pH7 and a final inoculum of lo4 cfu/ml were used for BM, 
the endpoint of whch was determined macroscopically (MIC) and 
also spectro-photometrically at 550nm absorbance to ascertain the 
OD80 and OD50 of the strains. E-tests were performed following 
the recommended pmcedure using RPMI agar for AMP and 5FC 
and Casitone agar for FLU and ITR. Both the E-test and BM tests 
were incubated at 35°C for 48 hrs. 
Results: Using breakpoint criteria each result was classified as S, 
I or R. Takmg the OD80 as the standard the results were further 
classified into Major (M) or Minor (rn) errors. E-Test: AMP- OM 
Om, 5FC- OM 51x1, FLU- 1M 12m, ITR- 1M 5m errors. MIC: 
AMP-OM 2m, 5FC- OM Om, FLU- 3M 4m, ITR-1M 7m errors. 
OD50- AMP- OM Om, 5FC- 1M Om, FLU- 7M Om, ITR- 
6M Om errors. It was concluded that the E-test was quick and 
simple to perform and that the results compared favourably with the 
OD80 results and would therefore be suitable for routine antifungal 
susceptibility testing. 
Determination of the in Viiro Activity of 
Antifungal Agents Against Candida Species by 
the E test 
J. Abb, H. Breuninger. Institute ofMicrobiology, Minikum Ludwigsburg, 
hdungsburg, Germany 
166 clinical isolates of Candida species (108 strains of C. albicans, 33 
strains of C. glabrata, 18 saains of C. tropicalis, 4 strains of C. krusk, 2 
strains of C. pseudotropicalis, and one s t r a i n  of C. guilliermondii) were 
tested for antifungal (amphotericin B, fluconazole) susceptibihty by 
the E test agar &sion method. Results of MIC determinations are 
summarized in the table. 
In via0 ictincy o f w h o t e n c m  B and fluconvole agltnst dirncd isolates of Candida species 
~ 
Can&& species Amphoterinn B Fluconazole 
MlC50 MIC90 MIC50 MIC90 
C. zlbicans (108) 0.032 0.125 0.19 0.38 
C. glabrau (33) 0.19 0.38 3.0 6.0 
C. tropic& (18) 0.094 0.25 0.75 3.0 
c .  h s e l  (4) 0.5 32 
Other C. spec. (3) 0.25 0.125 
Only two of the 108 C. albicans isolates and one of the 18 C. 
tropicalis isolates showed resistance to fluconazole. Higher resistance 
rates were observed in C. glabrata isolates (8 resistant strains out of 
33) and in C. h s e i  isolates (dl 4 strains resistant). None of the 166 
yeast isolates showed resistance to amphotericin B. 
The simple technology of the E test makes it a useful alternative to 
conventional methods for antifungal susceptibility testing of yeasts. 
80 Journal of Clinical Microbiology and Infection, Volume 3 Supplement 2 
I P359 I Evaluation of a New Antifungal Susceptibility 
M.L. Garrigues ', M. MalliC *, B. Dupont ', J.M. Bastide ', 
K. Tmtelnot4, R. Cisterna', B. Carles', E Dromer3. 'Sanofi 
Diagnostics Pasteur, Mama,  Paris, ZUniumid de Monfpellier, Pans, 
31nstihrt Purpur, Paris, 4Roberf Koch Institute, Berlin, Paris, 'Hospital 
Basurto, Bilbao, Pans 
Objectives: Fungitest is a micromethod in RPMI liquid medium, 
using a standardized inoculum (10' CFU/ml) as recommended by 
the NCCLS, with 2 modifications, the addition of glucose and a 
redox colored indicator for optimization of readings at 48 H. The 
aim of the study was on the one hand to study the correlation 
of the method with the reference NCCLS method and to select 
breakpoints adapted for routine use of the gallery, and on the other 
hand to test the ease of use and reproducibihty of the technique. 
Methods & Results: In a first phase, prototype galleries (using 
the modified medlum) were evaluated with 32 strains; global concor- 
dance with the NCCLS standard varied h m  80 to 86% depending 
on the site, Montpelier or Paris. Reproducibility was tested by ex- 
tendmg the study to 2 other sites, Berlin and Bilbao, who obtained 
highly correlated results for each antifungal drug, in testing 28 strains 
in parallel. In a second phase of the study, the disaibution of M.I.C. 
was studied for a to& of 193 strains. Based on the histograms as 
well as pharmacological data, 2 concentrations were chosen for each 
drug, in order to allow for a classification of the strains according to 
their in vim Susceptibility. 
Conclusion: In its final presentation, the Fungitest gallery with 2 
concentrations per drug is very simple to use and to read. Comple- 
mentary studies are needed to darlfy the relation between in vim 
results and in vivo activity of antifungal drugs. 
Test Gallery 
F] In Vitro Susceptibility Testing of Clinical Candida 
Isolates: Comparative Evaluation of Various 
Methods with the Reference NCCLS Method 
S. Arikan, D. Giir, M. Akova. Hacetfepe University School OfMedicine, 
Ankara, Turkey 
Objectives: To evaluate the correlation of Etest, microdilution and 
colorimemc microddution methods with the reference macrodilu- 
tion method for amphotericin B and fluconazole susceptibility in 
yeast isolates. 
Methods. One hundred and one Candida st ra ins  [ C .  albicans (53), 
C. h e i  (18), C .  kt& (15), ?: glabrata (7), C. tropicalis (6), C. para- 
psilosis (2)] isolated h m  91 immunocompromised patients were in- 
cluded in the study. In vim activity of amphotericin B and ~~UCOIM- 
zole was tested by reference macrodution, Etest, microdilution and 
colorimetric microdilution method. 
Results Minimum inhibitory concentration values of fluconazole 
for Candida h s e i  and Towlopsis glabrata isolates were found to be 
relatively higher compared to other species. The results of Etest, 
microdilution and colorimetric microdilution methods were found 
to be well-correlated with those of reference macrodilution method 
after an incubation period of 24 and 48 hours (overall agreement 
rates varying fium 8693% for amphotericin B and 8 4 4 9 %  for 
fluconazole). 
Conclusion: The results of study indicate that these methods are 
practical and reliable alternatives to the present reference macrodilu- 
tion method. 
1 P361 I Comparison of E Test and Microbroth Dilution 
for Antifungal Susceptibility Testing of M s t s  
Y. Ye&no& Z. Emran, 0. A@, M. Uzun. Deparfment 4 
Mhbiology  and Clinic Microbiolosy Istanbul Faculty 4 Medicine, 
Lttanbul, Turkey 
This study is a comparative evaluation of the E Test versus micmdi- 
lution susceptibility testing of amphotericin B (AMP), flucytosine 
(5 FC), fluconazole (FCZ), intraconazole (ITZ) and ketoconazole 
(KTZ) We have tested 40 chical and 2 quality control yeast isolates: 
22 C. albicans, 5 C. glabrata, 5 C. parapsilosis, 4 Trichosporon spp, 
3 C. krusei, 1 C. tropicah, I C. kefyr and 1 Sacchmmyces spp. 
The E Test was performed accordmg to the manufacturers instruc- 
tions. Two me& were tested for E Test: RPMI 1640 and HRM 
(high resolution medium) The microdilution susceptibility testing 
was performed by following the guidelines of the reference method 
(NCCLS, 1992). The broth was RPMI 1640. The MICs values were 
read at 24 h incubation. The results are summarized below. 
Oved percent iqccment within f 1 d i l u t i o ~  
E Test RPMU E Test HRM/ E Test HRM/ 
















* Len -merit bcfwecn E Test and mmddunon on the fwo medm (lw reproduabd- 
icy w h  f 1 dd h o n g  the five drugs tcstcd. 5FC md AMP dcmommtcd the best 
agreement (>5G%). 
Ip362j Standardization of In Viiro Disk Susceptibility 
Testing of Candida Species.Using Biomic: A 
Pilot Study 
J.H. Sloos, J.A. Kemme, H.EL. Guiot, C.l?A. van Boven. Leidm 
U n i m i t y  Hospital, Leiden, The Nethedands 
Reading and interpretation of disk diffusion zone diameters remains 
subjective for most fungi. In this pilot study, the fluconazole disk 
&sion method (Barry and Brown, 1996) was performed for 35 
Candida isolates, consisting of 8 species including 17 C. albicans. 
Zone diameters were read after 24 hours using Biomic (Gila Scien- 
dic, Ny, USA), an automated reader which measures disk ditfusion 
zone diameters. Results obtained were compared with the standard 
macrodilution method (NCCLS, 1995). Main goal was to evaluate 
Biomic for consistent reading of zone diameters. In general, Biomic 
facilitated the interpretation of zone sizes due to enhancement of 
the contrast of the zones on screen. Visually incorrect zone size 
measurement was observed in a relatively large proportion (21/35) 
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of readings. In these cases, readings were manually adjusted by mouse 
on screen. 
The figure demonstrates the correlation between MICs and zones 
after adjustment. Regression statistics (y = 37.2 - 3.69~; x = logz 
(MIC), y = zone diameter) defined zones 226 mm (MIC 5 8 
pg/ml) for susceptible and 515 mm (MIC 5 64 pg/ml) for resistent 
strains. Zone size limits have yet to be defined more precise for each 
species separately in broader studies. Currently, the Biomic program 
is being refined for the reading of Candida spp., possibly leading to 
standardized reading and interpretation of zone diameters for fungi. 
lp3631 In Vim Susceptibilities of Candida Albicans 
Isolates from the Oral Cavities of HIV Infected 
Patients 
S .  Mitrovic ’, V. Radwic I ,  I. Kranjcic-Zec ’, DJ. Jevtovic I .  
‘Institute ofhjctiour and Tropical Diseases, Clinical Center o Serbia, 
Yugoslavia, 21mtitute ofMicrobiology and Immunology, School o Medicine, 
Belgrade Universify, Belgrade, Yugoslavia 
Objectives: The purpose of this study is to determine the in vitro 
anhfungal susceptibilities of Candida albicans strains isolated h r n  
the oral cavities of HIV infected patients. 
Methods: Candda albicans strains were isolated h m  the oral 
cavities of 74 HIV infected patients at Merent stages of HIV mfec- 
tion. The mufungal activity o nystatin, arnphotericin B, flucytosine, 
dotrimazole, miconazole ketoconazole, fluconazole and itraconazole 
against all 74 isolates was evaluated by disk a+ &sion method. 
Results: Seven strains were resistant to nystatin, two to ampho- 
tericin B, four to flucytosine 23 resistant to miconazole, 24 to dotri- 
mazole, 54 to itraconazole, 59 to fluconazole, 62 to ketoconazole. 
Conclusions: We found no evidence of decreasing poliene and 
flucytosine susceptibility in C. albicans strains and sigdkmtly less 
susceptibility to azoles in vim, especially to itraconazole, fluconazole 
and ketoconazole. Whether these results give a rehble prediction o 
in vivo response behooves the evaluation of the clinical outcome in 
H N  infected patients with oropharyngeal candidiasis. 
I P364 I In Vim Activii of L742,872, a New 
Pneumocandin Against Candida Species 
J.A. Kemme, J.H. Sloos, H.EL. Guiot, C I A .  van Boven. Leiden 
University Hospitnl, Leiden, The Netherlands 
Increasing resistance of Candida spp. to fluconazole has propelled in- 
terest in the development of other anthycotics. In this study, in 
vitro activity of L742,872 (MSD, Haarlem, Nederland), a new water 
soluble member of the pneumocandms was compared to that of flu- 
conazole. In total, 35 strains encompassing 8 species, indudmg 17 C. 
albicans and 7 C .  glabrata isolates were selected on the basis of vary- 
ing susceptibilities to fluconazole determined in a pilot study. MICs 
were determined in duplo using the tentative standard macrodilution 
method (NCCLS, 1995). MIC ranges and MIC~O/MIC~O results are 
reported below: 
~ 
Species N MlCs (&d) L742.872 MlCs @g/ml) fluconazole 
nnge MICW MlCgo nnge MICm MIC 
C. dbirnns 17 0.25-4 2 2 025-16 0.5 4 
C. gbbmn 7 0.5 -8 2 4 2->256 32 64 
Otherrpp. 11 0.5 -8 2 4 1 4 4  16 64 
Toul 35 0.25-8 2 4 0.25-256 2 64 
All isolates tested with L742,872 showed MICs 5 8 pg/ml. MICs 
of L742,872, for fluconazole resistant strains (MIC 2 64 pg/ml) 
varied between 0.75-8 pg/ml. C. albicans s t r a i n s  were susceptible for 
both drugs, except one s t r a i n  which was intermediate susceptible for 
fluconazole. Results indicate that L742.872 is active against Merent 
Candida spp., includmg fluconazole resistant s&.ins. 
lP365 I In Vim Activities of LY303366, Arnphotericin B 
and Fluconazole against Yeasts Isolated in a 
Turkish University Hospital 
0. Uzun, S .  Kocagoz, Y Cetinkaya, S. Ankan, S .  Unal, Hacettepe 
University School of Medicine, Ankara, Turkey 
Objectives: To evaluate the in vim activity of LY303366, a new 
semisynthetic echocandin B analogue, against yeasts. 
Methods: The test organisms included 10 Candida albium Amer- 
ican Type Culture Collection (ATCC) strains (no. 64544 through 
64552, and no. 90028), C. parapsihis ATCC 90018, C. globrota 
ATCC 90030, and 245 isolates horn 239 patients. The MICs of all 
antlfungal agents were determined in accordance with the National 
Committee for Clinical Laboratory Standards M27-T standards by a 
microdilution method. 
Results: 
Yeast (n) MlC50/MIC90 (mcg/ml) 
Fluconawlc Amphotericin B LY303366 
C. &cam (164) 
C. brurri (34) 
C kcfr(16) 
C. ghbmta (12) 
C. tmpirnlis (11) 
C. pampsiloris (3) 
C &mafa (1) 

























Conclusion: LY303366 is a promising anhfungal drug that ex- 
hibits good in vitro activity against not only Candida species known 
to be usually susceptible to fluconazole such as C. albicans, but also 
the putatively fluconazole-resistant C. knrsei and C. glabrata. 
In Vim Susceptibility of Itraconazole-resistant 
Isolates of Aspergillus fumigatus to 
Voriconazole 
E.K. Manavathu, J.L. Cutright, PH. Chandrasekar. Wayne State 
Universify, Detroit, M I  48201, USA 
Voriconazole (VCZ) is a new investigational triazole which exhibits 
excellent antifungal activity against a wide spectrum of fungi, includ- 
ing A. jumigatw. Since the effectiveness of VCZ against itraconazole 
(1TZ)-resistant A. jumigafuus has not been studied, we examined the 
in vitro susceptibility of ITZ-resistant and -susceptible clinical and 
laboratory isolates [mean minimum inhibitory concentration (MIC) 
ofamphotericin B = 1.15 f 0.79 pg/ml; n = 961 ofA.+migafus to 
VCZ. Conidial suspensions were prepared h m  various isolates and 
their in vitro susceptibility to VCZ and IT2 was investigated using 
a broth macrodilution technique (Manavathu ef al., 1996; Can. J. 
Microbiol. 42: 960-964). A comparison of the mean MIC values of 
VCZ (0.83 f 0.57 pg/ml; n = 42) and IT2 (0.60 f 0.76 p g / d ,  
n = 73) for ITZ-susceptible A. fumigatuc isolates showed no sigmf- 
icant Merence. On the other hand, the mean MIC value of VCZ 
(1.46 f 0.59 pg/ml, n = 23) was $5 8 fold lower than that of IT2 
(11.30 f 4.77 p g / d ,  n = 23) for ITZ-resistant isolates. Although 
VCZ and ITZ are members of the azole family of ancifungals and 
have s d a r  mode of action, these p r e b a r y  data suggest that VCZ 
has therapeutic potentd against A.&migatus, including ITZ-resistant 
isolates. 
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[p3671 Frequency of Fluconazole (F) and ltraconazole (I) 
Resistance in HIV Infected Patients 
M. ChCron, Z. Le Lostec, S. Fegueux, Y. Weker, l? Mornet, 
A. Boisivon. C Hospitalier de Saint Germain en Laye, France 
To evaluate F and I yeast resistance in oropharyngal candidiasis in 
78 HIV patients, an oral swab was systematically collected for ev- 
ery patient from Mars to May 96. They were plated on Sabouraud 
dextrose agar. Yeasts were idended by Auxacolor (Diagnostics Pas- 
teur). F and I susceptibilities were determined on Casitone agar with 
E-test. Resistance was >8 mg/l for F, >4  for I .  The andfungal 
treatment during the proceedmg month was noted as well as the 
biological parameters. A yeast was isolated in 32 patients C+ (41%) 
and 8 (25%) had h c a l  signs. 10 (31%) had anthngal treatment 
(3 local amphotericine B and 6 oral fluconazole and 1 intravenous 
amphotericine B). No yeast was isolated in 46 patients C-; 7 (19%) 
had treatment (3 local and 4 oral F). No Merence was observed 
between the C+ and C- population for the clinical and biological 
state. No Merence was detected between the state of AIDS (A or 
C). 27 C. albicans (CA), 4 T. glabrata (TG), 1 C. tropicalis were iso- 
lated. Resistance was observed to F in 5 cases (15.6%): 3 TG, 2 CA. 
Cross resistance to F and I was observed in 4/5. Only one patient 
was under F therapy for cryptococcose (TG) and the other under 
Ampho B (CA). Our rate of yeast resistance to F and I is 15%. This 
resistance is not correlated with the state of illness. 
Molecular fungal diagnosis and resistance 
Fl Rapid Diagnosis of Disseminated Candidiasis by 
DNA Amplification of Common Regions from 
Candida albicans Secreted Aspartic Proteinase 
Genes 
M. Flahaut', D. Sanglard', M. Monod', J. Bille', M. Rosier3. 
'Institut de Minobiologie, Switzerland, 'Laboratoire de Mycologie, 
Dermotologie, Switzerland, ' CHUY Lausanne and HSpital de Zone, 
Morges, Switzerland 
Background: Disseminated c a n d i b  is a major nosocomial in- 
fection especially in immunocornpromised patients. Presently, blood 
culture and microscopy are the standard methods for detection of 
Candida sp, but dugnosis is often delayed due to the slow growth of 
the pathogen h m  dinical samples. Several studies seem to indicate 
that PCR might be a useful test for the early and sensitive detection 
of candidiasis. 
Method and Results: An improved method of DNA extraction 
fbm &cal samples based on a treatment with proteinase K and 
isolation of DNA on a silica membrane was developed. The targets 
used for DNA amplification are the Candida secreted aspartic pro- 
teinases (SAPS) genes, a multiple gene family of at least 7 members 
in C. albicans. A single pair of primers was designed in order to detect 
6 of these SAP genes and subsequently to increase the sensitivity of 
the test. The PCR product was then hybri&ed with a radioactive 
probe specific for the C. albicans SAP genes. A retrospective study 
was performed blindly on 94 clinical samples to compare the PCR 
ChCd Number Culture PCR S-blot False- "False- 
samples posruve poriuve pounve negruve pouuve" 
Blwddtu rc  47 22 20 21 1 0 
TO& 94 38 39 43 1 6 
'urine (n = 38). others (n = 9) 
Otbm' 47 16 19 22 0 6 
reSdk with those of culture. 
Conclusion: Compared with a previously developed assay based 
on the amplification of the lanosterol-demethylase gene (Bur- 
gener-Kairuz et al., JCM, 1994), this PCR assay is more sensitive 
(97%, single round PCR vs 76%, nested PCR), with a lower speci- 
ficity (89% vs 95%). This warrants a further prospective study with 
clinical specimens h m  patients at high risk for disseminated can- 
didiasis. 
1 P369 I Detection of Candida albicans by DNA 
Amplification using Nested Polymerase Chain 
Reaction 
Z.U. Khan, A.S. Mustafa. Dept. MinobioloD, Faculty ofMedicine, 
Kuwait University, Kuwait 
Objectives: To establish genus specific PCR and species specific 
nested PCR assays for specific identification of Merent Candida 
species and to test the suitability of PCR for detection of Candida 
in &nical specimens. 
Methob  DNA segments from the gene encoding cytochmme 
P450LlA1 were targeted for amplification by using genus and species 
specific primers. The yeast DNA was extracted fiom overmght 
grown cells using standard lysis b d e r  followed by DNA extraction 
by phenol and chloroform. Yeast lysis buffer containing zymolase was 
used to extract DNA from clinical specimens. Amplification condi- 
tions were standardized with respect to the concentration of MgCl2, 
anneahng temperature and DMSO. Amplified products were ana- 
lyzed by gel electrophoresis. 
Results: The genus speclfic primers (ZU5/ZU6) and the species 
specific primers (ZUS/ZU7) amplified 496 bp and 418 bp DNA, 
respectively, f b m  the genomic DNA of C. albicam. Species specific 
nested PCR improved the sensitivity of genus specific PCR by 1000 
times. A total of 21 specimens (2 urine + 19 blood) f b m  19 im- 
munocompromised subjeca were tested by culture and PCR. Both 
the tests were positive with 4 specimens. One specimen was culture 
positive but nested PCR negative whereas 4 specimens were nested 
PCR positive for C. albicans but culture negative. 
Conclusions: The nested PCR is a sensitive technique to detect 
C. albicans and other Candida species directly in clinical specimens. 
Efficacy of PCR for Detection of Deep Mycotic 
Infections - Confirmation by Autopsy 
J. Mayer I ,  A. KoMiik 2 ,  J. Vorlirek I ,  J. &ulovi 3,  V. Kubilek 3 .  
'Dept. oflnfrmal Med., University Hospital, Bmo Bohunice, Czech 
Republic, *Institute ofBiophysics, Academy of Sciences, Bmo, Czech 
Republic, 'Dept. OfPathology 11, Pediatry Hospital, B m ,  Czech Republic 
Objectives: Deep mycotic infections are life threatening complica- 
tions in intensive cancer therapy but their dmgnostics is unsatisfac- 
tory. We have hied to develop a new test based on PCR method 
and have evaluated ik sensitidy and specificity. 
Methods: The primers were derived &om the fungus-specific re- 
gions of the I8SrDNA gene amp-g a 673 bp diagnostic Merit 
TAGGATAG-3). The blood samples have been drawn immediately 
after death and for the further analysis the whole blood was used. In 
(5-TGATCATCTTCGATCCCCTA-3 and 5-ACTTTCGATGG 
Autopsy PCR 
Poriuve (number of patients) Negative (number of pauents) 
PoritiW 11 
Negative 1 
1 
11 
